tickrz reports
Allergan plc (AGN)
Healthcare | Drugs
176.05  -0.60%
AGN vs DRUGS SECTOR & S&P 500
VALUATION
AGNSECTORS&P 500
P/E RATIO40.521.12
EV/EBITDA RATIO133.412.66
P/S RATIO3.796.52.25
P/B RATIO0.897.73.45
QUALITY
RETURN ON EQUITY-9%15.79%13.64%
RETURN ON CAPITAL-4.63%19.38%10.09%
NET MARGIN-6.46%14.46%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
1.59%
PAYOUT RATIO-13.63%
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
7 OUT OF 9
DEBT-TO-EQUITY43%
INTEREST COVERAGE-1x
CURRENT RATIO1.18
GROWTH
5 YR EPS GROWTH79.31%
5 YR SPS GROWTH26.02%
5 YR BPS GROWTH50.01%
Allergan plc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership